Speakers' Presentations - Day 2
Some presentations have not been posted at the request of the authors. Presentations are posted in the language in which they were submitted.
Plenary Panel: Transparency in Drug Regulatory and Funding Processes
By agreement, the panellists did not use PowerPoint presentations. Listen to audio files of their presentations here.
Session 11: Knowledge Transfer and Exchange
- Michael Allen
- Engaging Decision Makers in HTA Research: Lessons Learned from the Knowledge Transfer of CADTH's Emergency Department Overcrowding HTA
- Kirsten Gartenburg, Donna Champagne
Knowledge Translation of HTAs for Policy Makers
Donna Angus, Amy Wong
Session 12: Evidence-based Decision-Making on the Front Lines
- A Progress Report on The Alberta Regional Health Technology Assessment Demonstration Project
- Don Juzwishin
- Wendy Ungar
- Paule Poulin
- Ellen Balka, Janet Joy
Session 13: Challenging Policy Issues: Expensive Drugs for Rare Diseases, Pandemic Influenza, Assisted Reproductive Technologies
- Review of Issues Associated with Assisted Reproductive Technologies (ARTs) and Preimplantation Genetic Diagnosis (PGD)
- Michelle McIsaac, Robert Lee, Sandy Berzins
- Kirsten Garces
Session 14: Engaging Stakeholders
- Expanding Stakeholder Involvement: Targeted Education and Training
- Adrienne Stevens
- Cheryl Arratoon
- Amanda Hammill
- Katharina Kovacs Burns
- Julie Senécal, Peter Liu, Karmela Krleza-Jeric
Session 15: Interventions to Facilitate Evidence-Based Prescribing and Drug Use: Evidence to Inform Policy Decision Making
- Jeremy Grimshaw
Alain Mayhew
- Nancy Santesso